Wegovy Medicare Coverage Expands for Patients at Risk of Heart Disease – NPR Coverage
Des Moines, Iowa – Medicare beneficiaries who are at risk of heart disease can now access coverage for Wegovy, a new prescription weight loss medication. This development comes as a response to the growing obesity epidemic in the United States, which poses significant health risks, including heart disease, among other chronic conditions. Wegovy, also known as semaglutide, has shown promising results in clinical trials for helping patients with obesity lose weight effectively. By making this …